Reg Technologies (REGRF) 0.0181 $REGRF IIROC Trade Halt

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Reg Technologies (REGRF) 0.0181 $REGRF

IIROC Trade Halt - Reg Technologies, Inc.
Newsfile Corp - Wed Jul 06, 6:36AM CDT
The following issues have been halted by IIROC:

Reg Technologies Inc. and REGI U.S., Inc. Announce Additional Testing on the 375 Horsepower Engine
ACCESSWIRE - Tue Nov 10, 6:21PM CST
VANCOUVER, BC / ACCESSWIRE / November 10, 2015 / REGI U.S., Inc. ("REGI" or "RGUS" or "the Company" (PINKSHEETS: RGUS) (Frankfurt Stock Exchange: RGJ), and Reg Technologies Inc. ("Reg" or "RRE.V" or "REGRF" or "the Company" (TSX Venture Exchange: RRE.V) (PINKSHEETS: REGRF), are pleased to announce that additional testing on the 375 horsepower diesel engine will be completed in Spokane, Washington. The U.S. customs paperwork was completed with Derringer Brokers to allow the engine to return to the U.S. The engine was transported to Spokane Washington and is being prepared for spin testing at various RPMs with full lubrication and cooling in preparation for combustion testing.

Reg Technologies Inc. and Regi U.S., Inc. Announce Further Prototype Developments
ACCESSWIRE - Fri Oct 02, 8:02AM CDT
VANCOUVER, BC / ACCESSWIRE / October 2, 2015 / REGI U.S., Inc. (the "Company" (OTC Pink: RGUS) (PINKSHEETS: RGUS) (Frankfurt Stock Exchange: RGJ) and Reg Technologies Inc. (the "Company" (TSX Venture : RRE) (OTC Pink: REGRF) (PINKSHEETS: REGRF), are pleased to announce that several parties have expressed interest this year in working with REGI to develop prototypes that meet their future needs. Preliminary designs have begun to outline physical requirements for several sizes of prototype engines. The ranges of interest were from 165 horsepower down to 5 horsepower. The end use varied from propulsion for land air and sea to power generation for land air and sea. NDA's have been signed to allow REGI to share data with the appropriate parties, so they could begin estimates based on size and weight for their application. REGI has provided cost estimates for preparation and testing of the prototypes. The programs all include accelerated prototype development and production using state-of-the-art methods to minimize time and development costs.
RRE.VN: 0.025 (-0.005)

Reg Technologies Inc. and REGI U.S., Inc. Announce Further Tests with a Dynamometer Recommended by Paul Porter
ACCESSWIRE - Tue Sep 01, 8:01AM CDT
VANCOUVER, BC / ACCESSWIRE / September 1, 2015 / REGI U.S., Inc. (OTC Pink: RGUS) (PINKSHEETS: RGUS), (Frankfurt Stock Exchange: RGJ) and Reg Technologies Inc. (TSX Venture Exchange: RRE.V), (OTC Pink: REGRF), (PINKSHEETS; REGRF), are pleased to announce that the prototype is currently being assembled, and will be spin tested when assembly is complete. After spin testing, the engine will need to be tested on a dynameter in order to begin the fine-tuning of the combustion and determine the horsepower produced.

Reg Technologies Inc. and REGI U.S., Inc. Announce Test Bench Completed
ACCESSWIRE - Fri Jul 31, 8:15AM CDT
VANCOUVER, BC / ACCESSWIRE / July 31, 2015 / REGI U.S., Inc. ("REGI" or "RGUS" or "the Company" (OTC Pink: RGUS) (PINKSHEETS: RGUS) (Frankfurt Stock Exchange: RGJ.F) and Reg Technologies Inc. ("Reg" or "RRE.V" or "REGRF" or "the Company" (TSX Venture Exchange: RRE.V) (OTC Pink: REGRF) (PINKSHEETS: REGRF), are pleased to announce that a test bench was fabricated by New Concepts, located in Richmond, BC. The purpose of the new test bench is to allow the full assembly of the prototype on a bench designed to allow the installation of the oil pump, cooling piping and starter motor. The bench also must carry the weight of the engine and be stable during the spin testing.

Reg Technologies Inc. and REGI U.S., Inc. Announce Preparation of Test Facilities for 375 Hp Radmax(TM) Engine
eTeligis - Mon Jun 01, 8:00AM CDT
VANCOUVER, BC, Canada, via ETELIGIS INC., 06/01/2015 - - VANCOUVER, BC, CANADA /ETELIGIS/ REGI U.S., Inc. (OTC Pink: RGUS) (PINKSHEETS: RGUS) (Frankfurt Stock Exchange: RGJ) and Reg Technologies Inc. (TSX Venture Exchange: RRE.V) (OTC Pink: REGRF) (PINKSHEETS: REGRF), are pleased to announce that Paul Porter, our Chief Mechanical Engineer, is preparing test facilities for the 375 hp diesel engine in Richmond BC. He will populate the engine with the new seals and prepare it for full spin testing. This phase of testing should be the final set of tests prior to placing the engine on a dynamometer. The dynamometer testing will allow us to document friction, fuel efficiency, net horsepower and emissions.

Reg Technologies, Inc. and REGI U.S., Inc. Announce New RadMax(TM) Patent Application Submitted to U.S. Patent Office
eTeligis - Tue Apr 14, 12:18AM CDT
VANCOUVER, BC, Canada, via ETELIGIS INC., 04/08/2015 - - REGI U.S., Inc. (OTC Pink: RGUS) (PINKSHEETS: RGUS) ( Frankfurt Stock Exchange: RGJ) and Reg Technologies, Inc. (TSX Venture Exchange: RRE.V), (OTC Pink: REGRF) (PINKSHEETS: REGRF) are pleased to announce that REGI U.S., Inc. has submitted a new U.S. patent application, for approval, to the U.S. patent office. This new patent will integrate a RadMax generator into the RadMax engine, thus being able to produce electrical power for use in recharging batteries, putting power into the electrical grid or operating any electrical device.

Reg Technologies Inc. / REGI U.S., Inc. Announce Progress Report for 350 HP RadMax(TM) Diesel Engine
ACCESSWIRE - Thu Jan 08, 2:43PM CST
Reg Technologies Inc. ("Reg" or "RRE.V" or "REGRF" REGI U.S., Inc. ("REGI" or "RGUS"

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading